Niagen®: Clinical Trials

3 trials of Niagen®, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 recruiting, 1 completed. 2 Not applicable, 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Not applicable2Recruiting 2
Phase 11Completed 1
Phase 21Completed 1

Follow Niagen®: new trials by email Literature Review of Niagen® trials Research Report on Niagen®

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Nicotinamide Riboside, Vit B3 Analogue, and Brain Energy Metabolism
Niagen® - Healthy Adult
Not applicableRecruitingMassachusetts General Hospital502026-12-012026-10-28
Absorption and Tolerability of Injectable Administration of Niagen®+, as Compared to NAD+
Niagen®, NAD+, Placebo - Healthy Aging
Not applicableRecruitingNutraceuticals Research Institute702024-10-312025-04-09
NAD Therapy for Improving Memory and Brain Blood Flow in Older Adults With Mild Cognitive Impairment
Niagen®, Placebo - Mild Cognitive Impairment
Phase 1 / Phase 2CompletedUniversity of Delaware642019-03-202025-04-04

Conditions studied

Cognitive Dysfunction (1)

Sponsors

Massachusetts General Hospital (1)  ·  Nutraceuticals Research Institute (1)  ·  University of Delaware (1)

Countries

United States (3)

Top investigators

Christopher R Martens, Ph.D. (1)

NIH funding

K01AG054731 (1)